While serotonergic alterations have been observed in fatigued PD patients with positron emission tomography (PET) studies showing reduced serotonin transporter (SERT) binding in basal ganglia and limbic regions,15 selective serotonin reuptake inhibitors have shown limited efficacy in fatigue management.21 Here, SLC6A4 is linked to Parkinson disease.